Short Interest in Concord Medical Services Holdings Limited (NYSE:CCM) Drops By 60.1%

Concord Medical Services Holdings Limited (NYSE:CCM) was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totaling 2,980 shares, a decrease of 60.1% from the June 30th total of 7,461 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 77,063 shares, the short-interest ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a research report on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Concord Medical Services Stock Down 3.6%

NYSE CCM traded down $0.17 during trading hours on Wednesday, reaching $4.43. The company’s stock had a trading volume of 104,567 shares, compared to its average volume of 29,645. The firm’s 50-day moving average price is $4.67 and its 200-day moving average price is $4.27. The company has a quick ratio of 0.46, a current ratio of 0.48 and a debt-to-equity ratio of 1.33. Concord Medical Services has a 1 year low of $3.18 and a 1 year high of $6.98.

Concord Medical Services (NYSE:CCM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) earnings per share (EPS) for the quarter.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.